Antipsychotic News and Research

RSS
Antipsychotics are medicines used to treat the symptoms of mental disorders such as schizophrenia, depression, bipolar disorder (sometimes called manic-depressive illness), anxiety disorders, and attention deficit-hyperactivity disorder (ADHD). Sometimes medications are used with other treatments such as psychotherapy.
Cedars-Sinai pioneers method to identify dementia patients for better care

Cedars-Sinai pioneers method to identify dementia patients for better care

AI models for mental health hit generalizability snag

AI models for mental health hit generalizability snag

Brain receptor discovery opens door to new therapies for addiction and mental health

Brain receptor discovery opens door to new therapies for addiction and mental health

Leaky gut linked to depressive disorders: New insights into microbiota-induced epigenetic changes

Leaky gut linked to depressive disorders: New insights into microbiota-induced epigenetic changes

Study reveals altered time perception in early Alzheimer's stages, offering potential early diagnostic marker

Study reveals altered time perception in early Alzheimer's stages, offering potential early diagnostic marker

Music could hold the key to developing effective mental health interventions

Music could hold the key to developing effective mental health interventions

Study suggests concomitant antidepressant and statin use could prevent treatment discontinuation

Study suggests concomitant antidepressant and statin use could prevent treatment discontinuation

Pharmacogenomics holds promise for personalized dementia therapies

Pharmacogenomics holds promise for personalized dementia therapies

How does the Mediterranean diet impact insulin resistance and sensitivity in obese individuals?

How does the Mediterranean diet impact insulin resistance and sensitivity in obese individuals?

Pregnant and addicted: Homeless women see hope in street medicine

Pregnant and addicted: Homeless women see hope in street medicine

Esketamine outperforms one of the standard drugs for treatment-resistant major depression

Esketamine outperforms one of the standard drugs for treatment-resistant major depression

Research identifies characteristics linked with higher risk of sudden cardiac arrest in people with type 2 diabetes

Research identifies characteristics linked with higher risk of sudden cardiac arrest in people with type 2 diabetes

New study reveals genetic overlap between schizophrenia and cardiovascular disease risk factors

New study reveals genetic overlap between schizophrenia and cardiovascular disease risk factors

One health wake-up call: London's river data highlights environmental perils

One health wake-up call: London's river data highlights environmental perils

New study maps the spread of brain changes in psychosis

New study maps the spread of brain changes in psychosis

Antipsychotics are likely overprescribed among homebound patients with dementia, study shows

Antipsychotics are likely overprescribed among homebound patients with dementia, study shows

FDA approved Rexulti to be the first antipsychotic for treating agitation in elderly patients with dementia

FDA approved Rexulti to be the first antipsychotic for treating agitation in elderly patients with dementia

Antidepressants may help prevent bipolar depression relapse

Antidepressants may help prevent bipolar depression relapse

People with dementia end up in emergency care 1.4 million times a year

People with dementia end up in emergency care 1.4 million times a year

People with mental illness less likely to participate in cancer screening programs

People with mental illness less likely to participate in cancer screening programs

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.